Nasal Midazolam Effects on Childhood Acute Seizures
Authors:
- 1 December 2000
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 15 (12) , 833-835
Abstract
Sixteen children, aged from 2 months to 14 years, with a diagnosis of acute seizures and seen at Dr. Sami Ulus Child Health and Disease Center, were included in this study. Midazolam (5 mg/mL) 0.2 mg/kg was administered intranasally in 30 seconds by an injector. The heart rate, respiratory rate, blood pressure, and oxygen saturation were recorded at 0, 5, and 10 minutes after administration. The seizures of three (18.7%) patients terminated within 1 minute, of seven (43.7%) patients in 1 to 2 minutes, and of three (18.7%) patients in 2 to 5 minutes. However, three (18.7%) patients did not respond to treatment. As a result, it was concluded that intranasal midazolam administration is easy and effective. The half-life of midazolam is shorter than diazepam, and midazolam has fewer complications when compared with diazepam. It is easier to use in nasal drop and spray forms. (J Child Neurol 2000;15:833-835).Keywords
This publication has 12 references indexed in Scilit:
- Clinical Pharmacology of Midazolam in Infants and ChildrenClinical Pharmacokinetics, 1998
- Midazolam in treatment of various types of seizures in childrenBrain and Development, 1997
- Midazolam for premedication in children: Nasal vs. rectal administrationEuropean Journal of Anaesthesiology, 1997
- Midazolam in the treatment of status epilepticus in childrenCritical Care Medicine, 1993
- Transmucosal Administration of Midazolam for Premedication of Pediatric PatientsAnesthesiology, 1993
- Midazolam in treatment of epileptic seizuresPediatric Neurology, 1992
- Intrarectal Diazepam in Epileptic AdultsEpilepsia, 1992
- Midazolam in the treatment of epileptic seizures.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Midazolam: an effective intravenous agent for seizure control.Archives of Emergency Medicine, 1987
- A pharmacodynamic evaluation of midazolam as an antiepileptic compound.Journal of Neurology, Neurosurgery & Psychiatry, 1986